Startseite UR
![]() | Eine Stufe nach oben |
Harrer, Dennis Christoph
, Schlierkamp-Voosen, Tim, Barden, Markus, Pan, Hong, Xydia, Maria, Herr, Wolfgang, Dörrie, Jan, Schaft, Niels und Abken, Hinrich
(2025)
Chimeric Antigen Receptor (CAR) T Cells Releasing Soluble SLAMF6 Isoform 2 Gain Superior Anti-Cancer Cell Functionality in an Auto-Stimulatory Fashion.
Cells 14 (12), S. 901.
Harrer, Dennis Christoph
, Eder, Matthias, Barden, Markus, Pan, Hong, Herr, Wolfgang und Abken, Hinrich
(2024)
Ectopic PU.1 Expression Provides Chimeric Antigen Receptor (CAR) T Cells with Innate Cell Capacities Including IFN-β Release.
Cancers 16 (15), S. 2737.
Delacher, Michael
, Schmidleithner, Lisa
, Simon, Malte
, Stüve, Philipp
, Sanderink, Lieke
, Hotz-Wagenblatt, Agnes, Wuttke, Marina
, Schambeck, Kathrin
, Ruhland, Brigitte
, Hofmann, Veronika
, Bittner, Sebastian
, Ritter, Uwe
, Pant, Asmita
, Helbich, Sara Salome, Voss, Morten, Lemmermann, Niels A., Bessiri-Schake, Lisa, Bohn, Toszka, Eigenberger, Andreas
, Menevse, Ayse Nur
, Gebhard, Claudia
, Strieder, Nicholas
, Abken, Hinrich
, Rehli, Michael
, Huehn, Jochen, Beckhove, Philipp
, Hehlgans, Thomas
, Junger, Henrik
, Geissler, Edward K.
, Prantl, Lukas
, Werner, Jens M.
, Schmidl, Christian
, Brors, Benedikt, Imbusch, Charles D. und Feuerer, Markus
(2024)
The effector program of human CD8 T cells supports tissue remodeling.
Journal of Experimental Medicine 221 (2), e20230488.
Harrer, Dennis Christoph
, Li, Sin-Syue, Kaljanac, Marcell, Barden, Markus, Pan, Hong und Abken, Hinrich
(2023)
Fine-tuning the antigen sensitivity of CAR T cells: emerging strategies and current challenges.
Frontiers in Immunology 14.
Harrer, Dennis Christoph
, Bezler, Valerie, Hartley, Jordan, Herr, Wolfgang und Abken, Hinrich
(2023)
IRF4 downregulation improves sensitivity and endurance of CAR T cell functional capacities.
Frontiers in Immunology 14.
Thomas, Simone
und Abken, Hinrich
(2023)
CAR T cell therapy becomes CHIC: “cytokine help intensified CAR” T cells.
Frontiers in Immunology 13.
Kaljanac, Marcell und Abken, Hinrich
(2023)
Do Treg Speed Up with CARs? Chimeric Antigen Receptor Treg Engineered to Induce Transplant Tolerance.
Transplantation 107 (1), S. 74-85.
Harrer, Dennis Christoph
, Schenkel, Charlotte, Bezler, Valerie, Kaljanac, Marcell, Hartley, Jordan, Barden, Markus, Pan, Hong, Holzinger, Astrid, Herr, Wolfgang und Abken, Hinrich
(2022)
CAR Triggered Release of Type-1 Interferon Limits CAR T-Cell Activities by an Artificial Negative Autocrine Loop.
Cells 11 (23), S. 3839.
Holzinger, Astrid und Abken, Hinrich
(2022)
Treatment with Living Drugs: Pharmaceutical Aspects of CAR T Cells.
Pharmacology 107 (9-10), S. 446-463.
, Dörrie, Jan und Schaft, Niels
(2022)
Decitabine-Mediated Upregulation of CSPG4 in Ovarian Carcinoma Cells Enables Targeting by CSPG4-Specific CAR-T Cells.
Cancers 14 (20), S. 5033.
Volltext nicht vorhanden.
, Westermann, Jörg, Rehm, Armin und Höpken, Uta E.
(2021)
CXCR5 CAR-T cells simultaneously target B cell non-Hodgkin’s lymphoma and tumor-supportive follicular T helper cells.
Nature Communications 12 (1).
Volltext nicht vorhanden.
Beckhove, Philipp
, Edinger, Matthias, Feuerer, Markus, Gattinoni, Luca und Abken, Hinrich
(2020)
International Regensburg Center for Interventional Immunology (RCI) symposium on “Synthetic immunology and environment-adapted redirection of T cells”, 17–18 July, 2019, Regensburg, Germany.
Cancer Immunology, Immunotherapy 69, S. 677-682.
Chmielewski, Markus
und Abken, Hinrich
(2020)
TRUCKS, the fourth generation CAR T cells: current developments and clinical translation.
Advances in Cell and Gene Therapy 3, e84.
Publikationsserver
Publizieren: oa@ur.de
0941 943 -4239 oder -69394
Dissertationen: dissertationen@ur.de
0941 943 -3904
Forschungsdaten: datahub@ur.de
0941 943 -5707